0001140361-17-022149.txt : 20170524 0001140361-17-022149.hdr.sgml : 20170524 20170524163912 ACCESSION NUMBER: 0001140361-17-022149 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170524 DATE AS OF CHANGE: 20170524 EFFECTIVENESS DATE: 20170524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genoa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001540171 IRS NUMBER: 452463191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-283266 FILM NUMBER: 17867147 BUSINESS ADDRESS: STREET 1: 12636 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (619) 992-6488 MAIL ADDRESS: STREET 1: 12636 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 D/A 1 primary_doc.xml X0707 D/A LIVE 0001540171 Genoa Pharmaceuticals, Inc. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 (619) 992-6488 DELAWARE None None Corporation true Mark W. Surber, Ph.D. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Executive Officer Heather Preston 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Bruce Montgomery, M.D. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Executive Officer Tiba Aynechi 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Jonathan Leff, M.D. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Niall O'Donnell 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Ketan Patel 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Naveed Siddiqi 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Pharmaceuticals Decline to Disclose 06b true 0001140361-17-013115 2017-03-13 true true false 1 64915611 18207187 46708424 false 46 0 0 0 false Genoa Pharmaceuticals, Inc. /s/ Mark W. Surber, Ph.D. Mark W. Surber, Ph.D. Secretary 2017-05-22